Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Cognitive decline in psychotic disorders: A longitudinal matched case-control study.
Journal: Schizophrenia research. Cognition
Published: May 13, 2026
Quality of life in early-phase schizophrenia patients starting treatment with long-acting injectable vs. oral antipsychotic drugs: Data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST).
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: April 21, 2026
Xanomeline/trospium and suicide-related events in schizophrenia: An early pharmacovigilance analysis.
Journal: Schizophrenia research
Published: February 13, 2026
Moderate to severe negative symptoms predict low risk of symptoms worsening in schizophrenia patients in CATIE.
Journal: Schizophrenia research
Published: February 06, 2026
Negative symptoms in schizophrenia: Methodological challenges and emerging solutions for outcome measurement.
Journal: Neuroscience applied
Published: November 30, 2025
Persistent negative symptoms in the EULAST cohort: impact on functional outcome.
Journal: Schizophrenia (Heidelberg, Germany)
Published: October 18, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.
Journal: The American journal of psychiatry
Published: October 08, 2025
The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST).
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: August 24, 2025
Subjective well-being in early-phase schizophrenia patients using long-acting injectable versus oral antipsychotic drugs: Data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST).
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: August 19, 2025
Roluperidone monotherapy, a treatment for negative symptoms in schizophrenia.
Journal: The international journal of neuropsychopharmacology
Published: March 20, 2025
Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized?
Journal: Schizophrenia bulletin
Published: February 21, 2025
Last Updated: 09/26/2026